𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phosphate binders in CKD: chalking out the differences

✍ Scribed by Lesley Rees; Rukshana C. Shroff

Publisher
Springer
Year
2009
Tongue
English
Weight
322 KB
Volume
25
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The pathophysiology of early-stage chron
The pathophysiology of early-stage chronic kidney disease–mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat
✍ Sharon M Moe; J Scott Radcliffe; Kenneth E White; Vincent H Gattone II; Mark F S πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 274 KB

Chronic kidney disease-mineral bone disorder (CKD-MBD) is a systemic disorder that describes the complex bone and mineral abnormalities that occur in CKD. To understand the pathophysiology of CKD-MBD and determine whether the early use of phosphate binders would alter this physiology, we used a natu

Different Mg to Fe ratios in the mixed m
Different Mg to Fe ratios in the mixed metal MgFe hydroxy-carbonate compounds and the effect on phosphate binding compared with established phosphate binders
✍ H. Zhu; M. Webb; J. Buckley; N. B. Roberts πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

Due to the side effects of the current oral phosphate binders, there is a need for effective alternatives. A number of mixed metal hydroxy-carbonate compounds (MMHCs) based on Mg and Fe have recently been established as effective phosphate binders. We have now carried out further studies on the MMHC

Relative in vitro efficacy of the phosph
Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride
✍ Valerie Autissier; Stephen J.P. Damment; Richard A. Henderson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 194 KB

The high tablet burden and poor compliance associated with phosphate-binding drugs has led to a search for more potent agents. In vitro-binding studies were performed on the recently introduced binder, lanthanum carbonate (LC; Fosrenol), to compare its phosphate-binding affinity with sevelamer hydro